Showing results (61-70 of 79) with videos related to
Sort By:
Pageof 8
Blood Advances|October 5, 2020
BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphomaNenad Sejic, Lindsay C George, Rosemary J Tierney, et al.The Journal of Pathology|October 9, 2014
Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinomaLee Fah Yap, Sharmila Velapasamy, Hui Min Lee, et al.Journal of Virology|August 25, 2017
Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult CasesRachel J Abbott, Annette Pachnio, Isabela Pedroza-Pacheco, et al.Cancer Research|January 26, 2013
Phase I trial of recombinant modified vaccinia ankara encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patientsEdwin P Hui, Graham S Taylor, Hui Jia, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancerGraham S Taylor, Hui Jia, Kevin Harrington, et al.Plos Pathogens|March 28, 2015
Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African childrenShamanthi Jayasooriya, Thushan I de Silva, Jainaba Njie-jobe, et al.Cell Reports|March 3, 2023
Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent mannerGuerman Molostvov, Mariam Gachechiladze, Abeer M Shaaban, et al.The Journal of Pathology|March 5, 2020
The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancerSteven Hayward, Mariam Gachehiladze, Nahla Badr, et al.Iscience|October 11, 2021
The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recoveryEleni Syrimi, Eanna Fennell, Alex Richter, et al.Leukemia|June 10, 2026
Loss of systemic anti-viral immunity and LMP1-driven suppressive myeloid tumour niches converge to shape the immunobiology of Epstein-Barr virus-positive diffuse large B-cell lymphomaÉanna Fennell, Soi C Law, Alexander C Dowell, et al.Pageof 8